Northrop Grumman Corp

NOC is entrenched in a Stage 4 downtrend with confirmed support failure, reinforcing medium- and long-term bearish bias. Price is currently pulling back into the downward-sloping 9/20/50 EMAs and the 535–545 resistance zone, presenting a sell-on-rally opportunity. Execution is best at rejection near EMAs and the prior support-turned-resistance level.

• ↑Q2 EPS $7.68 vs est. $6.82; revenue rose 5% YoY to $10.88B.
• ↑Backlog reached $105B (+17% YoY) with a 1.84× book-to-bill ratio.
• ↓Negative earnings yield and profitability factors signal weak returns.